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ABSTRACT
Malignant neoplasm (MN) mortality worldwide ranks among the first four causes of death, in the 1990 decade (1-4). 
The aim of this work is to study the eight most frequent MN mortality rates, and especially that one caused by oral 
cancer (OC) in the province of Cordoba, Argentine Republic, in the period between 1975 and 2000, in order to analyze 
its characteristics and compare with other populations in America and Europe.  
Material and Methods: The data were provided by the provincial and national Health Ministry and Globocan 2000. 
Results: The highest male rates were those of Slovakia and France, prevailing lung and bronchus tumors; whereas in 
females the highest rate was that of breast cancer in the United Kingdom and Germany, and lung cancer in the United 
States. Regarding to OC in the populations under study, Slovakia and France held the highest rates for both sexes, being 
Cordoba and Argentina among the lowest values, especially in women. Tongue was the most frequent site in Cordoba 
(43.5%), followed by salivary glands (23.7%). Male prevailed over female and the oldest ages were observed in the period 
1995-2000. The mortality rates by MN in all sites increased 6.6% in both sexes, and by OC 77% in women within the 
period under study in Cordoba.
Oral cancer is a serious problem for public health causing great morbidity and mortality, a situation that has not im-
proved in decades. Mortality rates are an important tool towards implementation and planning of health policies and 
programs for cancer prevention.
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RESUMEN
A nivel mundial la mortalidad por neoplasias malignas (NM), figura entre las cuatro primeras causas de muerte en la 
década del 90 (1-4). El objetivo del presente trabajo, es estudiar la tasa de mortalidad por las ocho NM más frecuentes 
y especialmente por cáncer bucal (CB) en la provincia de Córdoba, República Argentina en el período 1975-2000, ana-
lizar sus características y compararla con la de otras poblaciones de América y Europa. Material y Métodos: los datos 
se obtuvieron del Ministerio de Salud de Córdoba y Argentina y de Globocan 2000. Resultados: en el sexo masculino 
se observó que los países con más alta tasa fueron Eslovaquia y Francia, siendo los Tumores más prevalentes los de 
pulmón y bronquios. En las mujeres el Reino Unido, Alemania y EEUU fueron los países con tasa más alta y el Tumor 
más frecuente fue el de mama, excepto en EEUU donde el de pulmón lo antecede. En relación al CB en las poblaciones 
estudiadas, Eslovaquia y Francia fueron los países con tasa más alta para ambos sexos, estando los valores de Córdoba y 
Argentina entre los más bajos, especialmente en mujeres. En Córdoba la lengua fue el sitio más frecuente (43,5%), seguido 
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INTRODUCTION
Malignant neoplasm (MN) mortality worldwide ranks 
among the first four causes of death in the 1990 decade, 
together with cardiac and cerebro-vascular diseases (1-4). 
Oral Cancer incidence and mortality rates vary widely across 
the world. Oropharyngeal and oral cancer (OC) incidence 
in men is higher in the Bas Rhin in France, in the south 
of India, where is the most common cancer, in some areas 
in the center and east of Europe, and in some regions of 
Latin America (5, 6). The highest incidence was registered 
in India in women with a moderate rise in mortality in the 
central and Eastern Europe in the 1980’s and 1990’s (7). 
Cohort studies show that OC incidence has risen in all 
the age groups throughout the world in the last decades 
(6), especially in young men in Eastern Europe (7, 8). It 
was reported that the risk increased in 19 of 24 European 
countries, with an increment from three to tenfold within 
a single generation (9-11); however, a decreasing tendency 
was observed in OC incidence in some Latin American and 
Caribbean countries (5). Mortality rate is an important tool 
that provides implicit information about incidence, diagnosis 
stage, solving capacity of  health services, available tech-
nology and health programs to be applied, among others. 
However, comparisons are difficult considering that OC 
mortality rate and incidence data are not published using 
the same format (6). 
The aim of the this work is to study the mortality rates of 
the eight most frequent MN, and especially that caused 
by OC in the province of Cordoba, Argentine Republic, 
in the period between 1975 and 2000, in order to analyze 
its characteristics and compare with other populations in 
America and Europe.  
MATERIAL AND METHODS
Source
In the first stage the eight most frequent MN mortality ra-
tes were analyzed, and then the OC mortality rate. Cancer 
mortality data in Argentina and Cordoba, age-adjusted 
every one hundred thousand individuals, period 1997-2001, 
were provided by the Argentine Health Ministry (12). These 
were compared against USA and the following European 
countries: Spain, France, Germany, Slovakia, and United 
Kingdom according to Globocan 2000 (13). Death and 
population data in Cordoba, were provided by the Statistics 
Department of Cordoba Health Ministry.
Rate Calculation in Cordoba
Crude mortality rate was calculated by the following for-
mula: Cr = (Dn / Tp) x 100,000, where Cr: crude rate every 
100,000 persons, Dn: population death number in a definite 
period of time, and Tp: total population in the same period 
of time. For specific sex rate the formula is Sr = (Sdn / Sp) 
x 100,000, where Sr: Specific sex rate every 100,000 persons, 
Sdn: sex death number in each sex for a given population 
in a specific period of time, and Sp: total population of the 
sex under study, along the same period of time.
Rate behavior analysis
To analyze the rate behavior, five years were considered 
and the change percentage was assessed according to the 
following formula: (T-It) x 100/It, where T is the average 
rate over each period being it crude or specific for sex, and 
It the 75-79 rate, considered as the initial period. The sex, 
age and site distribution of death for OC in Cordoba, was 
also under analysis. In the present study OC is defined as 
any MN located in lip, tongue, mouth floor, gum, palate, 
buccal mucosa or salivary glands (ICD-9: from 140 to 145, 
ICD- 10: from 00 to 08); tonsils, hipo, naso and oropharynx 
codes were excluded (14). Up to 1996 the International Clas-
sification of Disease 9º revision (ICD-9) was used, and from 
1997 it was replaced by the International Statistical Classifi-
cation of Disease and health-related problems 10º revision 
(ICD-10). The ICD-9 used codes 140 to 145, namely: 140: 
lip, 141: tongue, 142: salivary glands, 143: gum, 144: mouth 
floor, and 145: other parts in the mouth. ICD-10 includes 
code 00: lip, 01: base tongue, 02: other parts and those not 
specified in tongue, 03: gum, 04: mouth floor, 05: palate, 06: 
other parts and not specified in mouth, 07: parotid gland, 
08: other major salivary glands and those not specified. Due 
to this update nomenclature the data were analyzed in two 
distinct periods: 1975-1996 and 1997-2000.
RESULTS
When considering mortality caused by tumors regardless 
of the site, in the 1997-2001 period in male population, the 
countries with highest mortality rate were Slovakia and 
France, followed by Germany and Spain, with prevalence 
of lung and bronchial tubes tumors. In women, the United 
Kingdom, Germany and USA ranked among the countries 
with highest MN rates being breast neoplasia the most 
frequent, with the exception of USA where lung cancer 
was prevalent over the rest. Regarding to OC, Slovakia and 
France head the list with highest rate in both sexes, with 
Cordoba and Argentina ranking among the lowest values, 
de glándulas salivales mayores (23,7%); predominó el sexo masculino y las edades promedio más altas se observaron en 
el período 1995-2000. Al analizar el comportamiento de las tasas de mortalidad se destacó que las NM en ambos sexos 
en Córdoba aumentaron el 6,6%, y la mortalidad por CB en mujeres se incrementó un 77% en el período estudiado.
El CB es un serio problema de salud pública que causa gran morbilidad y mortalidad no habiendo mejorado en déca-
das. Las tasas de mortalidad son un instrumento importante para la diagramación de políticas y programas de salud 
orientados a la prevención del cáncer.
Palabras clave: Cáncer bucal, mortalidad, neoplasias malignas, Argentina.
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Country All sites Oral 
 
Breast Colon and 
rectum 






 Male Female Male Fem Female Male Fem Male Fem Male Fem Male  Male   Fem Cerviz other 
Argentine* 148.0   93.6 1.9   0.5 20.4 14.5   9.0 3.4   3.1 35.5   7.1 16,3 9.9   3.9     4.5   6.2 
Cordoba* 155.3   96.4 1.6   0.4 23.3 13.4   8.9 5.4   3.3 39.3   7.0 16.7 10.2   3.8     2.8   6.0 
France  201.5   98.0 4.4   0.8 21.4 18.3   12.1 6.1   3.9 48.5   6.7 19.2 8.0   3.6     3.5   2.1 
Germany ** 176.6   116.9 3.2   0.8 23.7 21.7   17.0 5.7   3.9 46.2   9.6 18.4 12.9   7.8     4.2   2.1 
EEUU** 161.8  116.4 1.8  0.8 21,2 15.9  12.0 6.6  4.2 53.2   27.2 17,9 4.5   2.3     3.3  2.0 
Slovakia** 217.8   108.8 9.5   1.0 18.4 28.0   16.1 7.1   3.7 60.7   7.8 14.3 16.9   7.3    5.4   5.2 
Spain ** 176.1   85.0 3.9   0.8 18,1 17.3   11.1 5.4   3.2 49.4   4.2 15.0 12.6   6.2    2.7   2.4 
United  
Kindom** 
171.0   128.0 1.8   0.8 26,8 18.7   13.8 4.9   3.3 48.6   21.1 18,5 10.1   4.8    3.9   1.7 
Sweden 137.9   104.0 1.3   0.7 17.5 14.4   11.5 5.1   3.3 22.6   12.6 27.3 7.4   4.0    2.9   2.0 
75-79 80-84 Change % 85-89 Change % 90-94 Change % 95-00 Change % 
159.3 158.7 -0.38 169.7 6.53 169.8 6.6 169.8 6.6 
Male Female 









Lip 45 (6.6%) 64 + 10 10 (6.1%) 73 + 12 4.5:1 
Tongue  308 (45.2%) 60 + 9 60 (36.4%) 61 + 16 5:1 
Salivary Gland 155 (22.7%) 64 + 10 50 (30.3%) 64 + 15 3:1 
Gum 15 (2.2%) 61 + 15 5 (3%) 57 + 10 3:1 
Mouth floor  48 (7%) 58 + 11 11 (6.7%) 65 + 10 4:1 
Other  
locations 
111 (16.3%) 60 + 12 29 (17.6%) 65 + 12 4:1 
Total 682 (100%) 61+  11 165 (100%) 64  + 12 4:1 
Table 1. Mortality Rates for the eight most prevalent MN, sex-specific (age adjusted, per 100,000 inhabitant), 1997-2001.
*1997-2001 National Health Ministry of Argentina (12).
**2000 Jemal et al (13)
Table 2. Average mortality rate for cancer in all sites for both sexes, in Cordoba Province period 1975-2000 and change percenta-
ge with respect to the first period.
Table 3. Death number for oral cancer. Sex and age distribution according to the location, in Cordoba Province, period 1975-
1996. (ICD-9) Code.
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especially in women (Table 1).
When analyzing the change percentage in the MN mortality 
rate regardless of site in the province of Cordoba in 1975-
2000 period, a 6.6% increment was observed (Table 2). 
Tables 3 and 4 show the number of deaths by OC in the 
province of Cordoba in the 1975-1996 and 1997-2000 pe-
riods respectively. Over a total of 1005 deaths in both sexes, 
the most frequent site was the tongue (43.5%), followed by 
the salivary glands (23.7%). When considering sex and age 
in death distribution by OC, male predominated, except in 
the 1997-2000 period when the M / F ratio comes closer to 
one, especially in the tongue that changed from 5 to 2.6. 
Regarding to age, mouth tumors ranked from 22 to 87 
years with a mean of 59.5. Older ages can be observed in 
the second period in all the sites for both sexes, especially 
in lips in women. In the first period the youngest average 
age was 57.7 for men with floor of the mouth tumors and 
57.5 for women with gum lesions (Table3), whereas in the 
second period the lowest ages were found in the tongue and 
mouth floor (Table 4). 
Change percentage in mortality rate was observed for OC, 
specifically for sex and in the period 1975-2000 (Fig.1). The-
re was a 59% increment in men until 1995 that decreased in 
the last period down to a value of the first period studied. 
In women the increment was gradual reaching 77% in 95-
2000 period (Table 5).
Male Female 









Lip 7  (5.8%) 72  + 9 2 (5.3%) 84 + 12 3.5:1 
Tongue 50 (41.7%) 61 + 11 19 (50%) 71 + 11 2.6:1 
Parotid 23 (19.2%) 66 + 13 10 (26.3%) 73 + 10 2.3:1 
Gum - - - - - 
Mouth floor 15 (12.5%) 61 + 11 3 (7.9%) 74 + 17 5:1 
Other Locationiz 10 (8.3%) 62 + 14 0 0 10:0 
Palate 15 (12.5%) 66 + 10 4 (10.5%) 74 + 8 3:1 
Total 120 (100%) 65 + 11 38 (100%) 76  + 12 3:1 
Sex 75-79 80-84 Change % 85-89 Change % 90-94 Change % 95-00 Change % 
Male 2.10 2.41 14.8% 2.33 10.9% 3.34 59% 2.06 -1.9% 
Female 0.39 0.54 38.5% 0.65 66.7% 0.58 48.7% 0.69 77% 
Table 4. Death number for oral cancer. Sex and age distribution according to the location, in Cordoba Province, period 1997-
2000. (ICD-10) Code.




























Fig. 1.  Mortality rate for oral cancer by gender in Cordoba province, 
period 1975-2000 (per 100,000 inhabitants).
E234
Oral Medicine and Pathology                                                                                                                           �  Oral cancer mortality              Med Oral Patol Oral Cir Bucal 2006;11:E230-5.                                                                                               � Oral cancer mortality 
© Medicina Oral S.L. Email: medicina@medicinaoral.com
DISCUSSION
While MN mortality regardless of site diminished by 1.1% 
average per year (13) in USA during the period 1992-1998; in 
Cordoba the rate increased by 6.6% in the period 1975-2000 
and is higher than that for Argentina (Tables 1 and 2). 
In the present work, when referring to OC, the codes con-
sidered were: 140-145 of the CIE-9 following Shiboski et 
al (14). When comparing with other authors we found that 
Moore et al studied only some sites in the mouth: 143-145 
(6), others include oropharynx: 141-146 (15), a significant 
number of authors studied mouth and pharynx cancer: 140-
149 (5, 7, 8, 11, 16-18) and in the last group are those that 
exclude lip, salivary glands, nasopharynx and hypopharynx 
(19, 20). The comparison with our findings is difficult due to 
the difference in the formats used by different authors.
OC mortality rate in men increased steadily until 1994 where 
it reached 59% higher than in the period 1975-1979. The 
phenomenon is similar to that observed in oropharynx can-
cer in some countries in Europe, such as Ukraine, Estonia, 
Hungary and Russia (7); in Cordoba however from 1995 
a diminution in mortality was recorded, a finding difficult 
to interpret but also observed in other populations such 
as San Pablo, Brazil (17), Switzerland, Sweden, Italy, and 
France (5,7).  
The age of OC patients was higher in the last period studied 
(Table 3), which correlates with the observations of Su et al 
in Japan (18). This is most likely explained by the National 
Institute of Statistics and Census (INDEC) (21) who con-
siders that if  the present demographic tendencies remain 
the same, cancer incidence and mortality in Argentina will 
continue moving towards older age groups (22). This is due 
to the increase in life expectancy from 68.44 to 69.55 years 
for men and 75.69 to 75.75 years for women over the period 
1995-2000 (1). The current tendency in Europe is toward 
an increase OC incidence in young adults, especially in 
tongue (23, 24). This observation could not be correlated 
with Argentina, due to the absence of official records of 
OC incidence in this country. OC is a disease that most 
predominantly affects males (25), there is however evidences 
showing an increase in oropharynx cases in middle-aged 
women, as described for central and eastern European 
countries (Slovakia, Belgium, Greek, and Czech Republic) 
over the period 1994-1999 (7). In Cordoba, although with 
a relatively low rate, a gradual increase can be observed 
reaching up to 77% higher in the period 95-2000 than in 
the first period under study (Table 5). These tendencies 
probably indicate a change in women habits, such as the 
increase in smoking or drinking alcohol (7, 26-29). A marked 
increment in alcohol and tobacco consumption has been 
observed lately in Argentina, reaching up to 30% to 50% 
in males economically active, together with an even higher 
percentage of adolescents showing this addictive behavior 
(30). An increment in MN incidence in the near future can 
be inferred from these data.
When analyzing OC sites, the tongue was the most frequent 
in males older than 50 years, which was similar to most of 
the studies (14, 15, 31, 32). In the last period under analysis 
(1995-2000) an increase in mortality rate in women showed 
a striking increase in lip tumors, where the M:F ratio shif-
ted from 4.5:1 to 3.5:1 and in tongue from 5:1 to 2.6:1. Lip 
cancer was the most frequent MN in the oral cavity and the 
predominant histological type is squamous cell carcinoma, 
representing 95% of the cases (33). Most of them occur in 
the lower lip semimucosa in white men chronically exposed 
to sun, in general with a good prognostic. There are also 
other MN that can take place in the lip, such as adenocarci-
nomas, more frequent in the upper lip in women, with a less 
favorable prognostic than that of squamous cell carcinoma. 
In the present work MN in lip was found to be 6.5% in men 
and 6% in women of the total deaths for OC respectively 
(Tables 3 and 4). Because these data could not be compared 
against incidence and histological type, the high percentage 
found in women can be attributed to the increase in solar 
exposure due to change of habits, and to a higher prevalence 
of adenocarcinomas as it was observed by other authors 
(34). Although an increase in incidence can not be directly 
related to an increase in mortality, it is important to notice 
the low mortality rate for MN in gum, considering that this 
is one of the most frequent sites affected, probably because 
this site is usually labelled as “other sites” (35-40). Argentine 
population was estimated around 36 millions in 2001, with 
an urban population of 88.6% in 1996 (1). Cordoba is a 
mediterranean province, with 3 million inhabitants, 50% of 
whom are located in the capital city where there are nume-
rous metallurgy and car related industries. There are regions 
in this province where the drinkable water contains high 
amounts of arsenic, which causes chronic hydro-arsenicism 
regionally endemic (HACRE in Spanish), favoring skin and 
oral cancer (41, 42). Table 1 shows that cancer mortality in 
all sites is higher in Cordoba than in Argentina. Because the 
differences in mortality rate between periods of time and 
geographic areas should be interpreted in terms of changes 
in exposure to risk factors (6), it would be of fundamental 
importance to go deeper into incidence and mortality stu-
dies in our province and relate them to the factors than may 
influence cancer etiopathology. 
OC is a serious public health problem that causes great 
morbidity and mortality and which has not improved in 
decades. It is therefore a true challenge in various regions 
of the world. The prognostic depends greatly on an early 
diagnosis of hazardous lesions in mouth; therefore keeping 
health professionals well trained is of utmost importance, 
particularly dentists and clinicians, in order to reduce OC 
devastating consequences over the world.
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